Genetic deletion of mPGES-1 abolishes PGE2 production in murine dendritic cells and alters the cytokine profile, but does not affect maturation or migration
- 29 December 2010
- journal article
- review article
- Published by Elsevier
- Vol. 84 (3) , 113-121
- https://doi.org/10.1016/j.plefa.2010.10.003
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Interleukin‐4 inhibits cyclo‐oxygenase‐2 expression and prostaglandin E2 production by human mature dendritic cellsImmunology, 2007
- Shunting of prostanoid biosynthesis in microsomal prostaglandin E synthase‐1 null embryo fibroblasts: regulatory effects on inducible nitric oxide synthase expression and nitrite synthesisThe FASEB Journal, 2006
- Is mPGES-1 a promising target for pain therapy?Trends in Pharmacological Sciences, 2006
- Dendritic-cell trafficking to lymph nodes through lymphatic vesselsNature Reviews Immunology, 2005
- Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma PreventionNew England Journal of Medicine, 2005
- Expression of microsomal prostaglandin E synthase 1 in rheumatoid arthritis synoviumArthritis & Rheumatism, 2004
- Inhibition of IL-6, TNF-α, and cyclooxygenase-2 protein expression by prostaglandin E2-induced IL-10 in bone marrow-derived dendritic cellsCellular Immunology, 2004
- Prostaglandin E2 inhibits production of the inflammatory chemokines CCL3 and CCL4 in dendritic cellsJournal of Leukocyte Biology, 2003
- Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cellsBlood, 2002
- Interleukin‐3 and granulocyte–macrophage colony‐stimulating factor enhance the generation and function of dendritic cellsImmunology, 1999